$188.17
-3.14-1.64%
Last update: Nov 2, 4:33 PM
Revolution Medicines Inc (RVMD) Stock Price, Quote, News & History
RVMDNASDAQ
Tango Therapeutics reports an 82% response rate in pancreatic cancer trials and prepares a randomized registrational study for early 2027.
You can purchase shares of Revolution Medicines (NASDAQ:RVMD) through any online brokerage.
Other companies in Revolution Medicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Revolution Medicines has a consensus price target of $202.07.
The stock price for Revolution Medicines (NASDAQ: RVMD) is $188.17 last updated November 2, 2026 at 4:33 PM EST.
There are no upcoming dividends for Revolution Medicines.
Revolution Medicines does not have any upcoming earnings scheduled.
There is no upcoming split for Revolution Medicines.
Revolution Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer...
